Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tissue Fixation | 1 | 2020 | 257 | 0.720 |
Why?
|
Paraffin Embedding | 1 | 2020 | 319 | 0.720 |
Why?
|
Lysine | 2 | 2020 | 1032 | 0.600 |
Why?
|
Histones | 2 | 2020 | 2580 | 0.400 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1607 | 0.380 |
Why?
|
Trans-Activators | 2 | 2019 | 3061 | 0.280 |
Why?
|
Prostatic Neoplasms | 5 | 2021 | 10660 | 0.270 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1372 | 0.210 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 188 | 0.200 |
Why?
|
Ikaros Transcription Factor | 1 | 2021 | 225 | 0.190 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 750 | 0.180 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 328 | 0.180 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 550 | 0.170 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 492 | 0.170 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 318 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2022 | 5238 | 0.160 |
Why?
|
Acetylation | 1 | 2020 | 1119 | 0.160 |
Why?
|
Receptors, Androgen | 2 | 2020 | 1063 | 0.160 |
Why?
|
Oncogene Proteins | 1 | 2020 | 764 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2021 | 8674 | 0.140 |
Why?
|
Oncogene Fusion | 1 | 2015 | 110 | 0.130 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2022 | 1102 | 0.130 |
Why?
|
Transcription Factors | 4 | 2021 | 12047 | 0.130 |
Why?
|
Oncogenes | 1 | 2017 | 1258 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1022 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2016 | 1157 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1566 | 0.090 |
Why?
|
Pyrimidines | 1 | 2021 | 2969 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7947 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2022 | 20059 | 0.090 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2020 | 173 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4688 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4918 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2970 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1923 | 0.070 |
Why?
|
Prostate-Specific Antigen | 1 | 2015 | 2274 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2325 | 0.070 |
Why?
|
Signal Transduction | 4 | 2021 | 23973 | 0.070 |
Why?
|
Proteins | 1 | 2020 | 6163 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 2094 | 0.070 |
Why?
|
Liver | 1 | 2020 | 7647 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11192 | 0.060 |
Why?
|
Mice | 5 | 2021 | 80995 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16943 | 0.060 |
Why?
|
Disease Progression | 2 | 2020 | 13302 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15258 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5000 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13732 | 0.050 |
Why?
|
Chromatin | 2 | 2022 | 2731 | 0.050 |
Why?
|
Genes, cdc | 1 | 2020 | 126 | 0.050 |
Why?
|
Mediator Complex | 1 | 2020 | 109 | 0.050 |
Why?
|
Prostate | 2 | 2020 | 1605 | 0.050 |
Why?
|
Prognosis | 2 | 2022 | 29168 | 0.050 |
Why?
|
Mutation | 2 | 2021 | 29442 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3460 | 0.040 |
Why?
|
Animals | 5 | 2021 | 170726 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 339 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 574 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 998 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 621 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 531 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1878 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 778 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 162 | 0.040 |
Why?
|
DNA Helicases | 1 | 2021 | 826 | 0.040 |
Why?
|
Amino Acids | 1 | 2021 | 1752 | 0.040 |
Why?
|
Data Mining | 1 | 2021 | 543 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5977 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1152 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 574 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 813 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1172 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 651 | 0.030 |
Why?
|
Humans | 13 | 2022 | 715124 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2016 | 433 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 922 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1425 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2173 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1121 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 829 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3694 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 583 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 20515 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2579 | 0.030 |
Why?
|
Male | 6 | 2021 | 351081 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2020 | 4321 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1208 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2611 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2862 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2457 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 1984 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3071 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3091 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3503 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4353 | 0.020 |
Why?
|
Female | 6 | 2022 | 377334 | 0.020 |
Why?
|
Aged | 2 | 2017 | 162674 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6779 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 16680 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4118 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 6046 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 7051 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6750 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9521 | 0.020 |
Why?
|
Middle Aged | 2 | 2017 | 214871 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9661 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11766 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22936 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12404 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5333 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10800 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11317 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 8925 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58505 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 56155 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 62186 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 70704 | 0.010 |
Why?
|
Adult | 1 | 2017 | 212129 | 0.000 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_